Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 01 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-15.76 Insider Own0.00% Shs Outstand2.37M Perf Week14.33%
Market Cap15.99M Forward P/E- EPS next Y-3.65 Insider Trans- Shs Float2.37M Perf Month24.84%
Income-23.85M PEG- EPS next Q-2.12 Inst Own14.92% Short Float0.86% Perf Quarter-13.21%
Sales0.00M P/S- EPS this Y54.70% Inst Trans12.75% Short Ratio0.94 Perf Half Y-29.60%
Book/sh5.79 P/B1.17 EPS next Y69.64% ROA-135.87% Short Interest0.02M Perf Year-66.02%
Cash/sh4.11 P/C1.64 EPS next 5Y- ROE-150.43% 52W Range4.55 - 23.00 Perf YTD-3.88%
Dividend Est.- P/FCF- EPS past 5Y-155.78% ROI-173.57% 52W High-70.66% Beta1.29
Dividend TTM- Quick Ratio9.54 Sales past 5Y0.00% Gross Margin- 52W Low48.30% ATR (14)0.59
Dividend Ex-Date- Current Ratio9.54 EPS Y/Y TTM53.55% Oper. Margin0.00% RSI (14)56.10 Volatility10.33% 10.01%
Employees15 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price40.50
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q67.48% Payout- Rel Volume1.35 Prev Close6.13
Sales Surprise369.60% EPS Surprise21.74% Sales Q/Q- EarningsNov 14 AMC Avg Volume21.61K Price6.75
SMA206.15% SMA508.79% SMA200-22.71% Trades Volume29,129 Change10.08%
Date Action Analyst Rating Change Price Target Change
May-19-22Resumed H.C. Wainwright Buy $22
Feb-08-21Initiated H.C. Wainwright Buy $31
Dec-07-20Initiated B. Riley Securities Buy $36
Aug-17-20Reiterated Maxim Group Buy $12 → $18
Jul-08-20Initiated Maxim Group Buy $12
Jan-24-24 08:00AM
Jan-09-24 08:00AM
Dec-20-23 10:52AM
Dec-19-23 06:00AM
04:01PM Loading…
Dec-18-23 04:01PM
Dec-15-23 07:00AM
Dec-13-23 08:00AM
Nov-30-23 08:00AM
Nov-27-23 07:00AM
Nov-16-23 08:37AM
Nov-14-23 04:05PM
Nov-08-23 04:05PM
Nov-07-23 04:05PM
05:00PM Loading…
Oct-02-23 05:00PM
Sep-28-23 04:29PM
Aug-23-23 07:00AM
Aug-17-23 04:01PM
Aug-16-23 04:25AM
Aug-15-23 06:05AM
Aug-14-23 04:01PM
Aug-09-23 08:30AM
Aug-08-23 05:50PM
Jul-31-23 07:00AM
Jun-26-23 07:00AM
May-23-23 04:05PM
May-11-23 04:05PM
07:15AM Loading…
May-09-23 07:15AM
May-04-23 08:00AM
May-01-23 07:00AM
Apr-08-23 08:58AM
Mar-07-23 04:15PM
Mar-06-23 04:05PM
Feb-23-23 01:01PM
Feb-08-23 04:05PM
Jan-09-23 08:00AM
Dec-05-22 06:30AM
Nov-29-22 04:01PM
Nov-21-22 01:40PM
Nov-18-22 08:00AM
Nov-17-22 04:01PM
Nov-14-22 04:01PM
Nov-07-22 04:05PM
Nov-03-22 08:00AM
Nov-02-22 12:47PM
Nov-01-22 04:07PM
Oct-18-22 10:23AM
Oct-11-22 08:00AM
Sep-26-22 08:00AM
Sep-22-22 08:00AM
Sep-08-22 08:00AM
Sep-06-22 08:00AM
Aug-12-22 11:30AM
Aug-11-22 04:05PM
Aug-02-22 04:05PM
Jul-14-22 08:00AM
Jun-24-22 03:44PM
Jun-09-22 08:00AM
Jun-01-22 08:00AM
May-31-22 09:55AM
May-20-22 09:32AM
May-11-22 05:15PM
May-10-22 03:34PM
May-02-22 08:00AM
Apr-29-22 07:30AM
Apr-28-22 08:04AM
Apr-19-22 08:00AM
Apr-05-22 09:09PM
Mar-25-22 12:00AM
Mar-24-22 05:45PM
Mar-17-22 11:07AM
Mar-11-22 07:05AM
Mar-09-22 04:05PM
Mar-07-22 10:16AM
Mar-01-22 08:00AM
Feb-24-22 02:29PM
Jan-27-22 08:00AM
Jan-12-22 09:34AM
Dec-21-21 08:00AM
Dec-06-21 08:00AM
Nov-16-21 01:00AM
Nov-15-21 05:25PM
Nov-08-21 08:03AM
Nov-05-21 04:05PM
Oct-28-21 12:03PM
Oct-14-21 03:05PM
Sep-23-21 11:07AM
TFF Pharmaceuticals, Inc. engages in the development and commercialization of drug products based on its patented Thin Film Freezing technology platform. It focuses on the manufacture of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company was founded on January 24, 2018 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CARLSON CAPITAL L P10% OwnerAug 16Sale0.391,0003925,064,000Aug 17 05:29 PM
Weisman Harlan FPresident and CEOAug 15Buy0.25600,000150,000814,615Aug 15 08:00 AM
Mikhak ZamanehChief Medical OfficerAug 15Buy0.25120,00030,000135,000Aug 15 08:00 AM
MILLS ROBERT SDirectorAug 15Buy0.2540,00010,00055,980Aug 15 08:00 AM
COLEMAN KIRK ALLENChief Financial OfficerAug 15Buy0.2520,0005,00035,675Aug 15 08:00 AM
Roberts BrandiDirectorAug 15Buy0.2520,0005,00020,000Aug 15 08:00 AM
ROCAMBOLI STEPHENDirectorAug 15Buy0.2520,0005,00036,000Aug 15 08:00 AM
CARLSON CAPITAL L P10% OwnerAug 15Sale0.44215,00094,0415,065,000Aug 17 05:29 PM
Weisman Harlan FPresident and CEOMar 10Buy0.88150,000131,835214,615Mar 13 08:00 AM
Mikhak ZamanehChief Medical OfficerMar 10Buy0.8215,00012,30015,000Mar 13 08:00 AM
ROCAMBOLI STEPHENDirectorMar 10Buy0.8013,00010,43216,000Mar 13 04:22 PM
COLEMAN KIRK ALLENChief Financial OfficerMar 10Buy0.7912,0009,45715,675Mar 13 08:00 AM